RAMNIK SINGH: Open Payments
NPI 1740223064 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$131 in 6 payments from 4 companies in 2025. Trend: 2023 $155 · 2024 $0 · 2025 $131
Food & beverage: $131
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Almatica Pharma LLC | 1 | $22 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, LOREEV XR.
Industry payments across DE — which companies pay providers there.
